DIFFERENTIAL-EFFECTS OF RECOMBINANT HUMAN COLONY STIMULATING FACTOR (RH G-CSF) ON STEM-CELLS IN MARROW, SPLEEN AND PERIPHERAL-BLOOD IN MICE

Summary Previously it has been hypothesized that the granulopoietic and erythropoietic lineages may compete for differentiating stem cells. According to this hypothesis one would expect that a stimulation of granulopoiesis by G‐CSF administration would lead to a reduction of the stem cell pool and be followed by a decline of erythropoietic progenitor numbers. In addition one would expect an enhanced response of granulopoiesis if G‐CSF administration were combined with suppression of erythropoiesis by red cell transfusion. To evaluate whether this hypothesis holds true C57bl mice were injected subcutaneously for 6 d with 3. 75 μg rh G‐CSF/ mouse/d (150 μg G‐CSF/kg body weight/d). Marrow CFU‐S numbers showed an increase to 160% on day 2, followed by a decrease to 50% of control on day 6. Splenic and peripheral blood CFU‐S increased 20‐fold and 10‐fold, respectively. Marrow CFU‐E declined to 40% of the control value. Splenic CFU‐E increased 10‐fold. The increase in marrow CFU‐GM numbers ranged between 140% and 180%. CFU‐GM obtained from the spleen and the peripheral blood increased 60‐fold and 15‐fold. respectively. Regarding the CFU‐S and CFU‐GM a similar pattern of response was found in an experiment where rh G‐CSF administration was combined with an additional red cell transfusion. These data do not provide convincing evidence for an exhaustion of haemopoietic stem cells during treatment with G‐CSF. They rather suggest that an important side effect of G‐CSF treatment is a release of CFU‐S and progenitors from the marrow to the peripheral blood and a reseeding in the spleen. Copyright © 1990, Wiley Blackwell. All rights reserved